Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jul 2008

Fidanci Inanç D, Kavakli Kaan, Uçar Canan, Timur Cetin, Meral Adalet, Kilinç Yurdanur, Sayilan Hülya, Kazanci Elif, Cağlayan S Hande

Abstract excerpt

Factor VIII (FVIII) replacement therapy is ineffective in hemophilia A patients who develop alloantibodies (inhibitors) against FVIII. The type of factor 8 (F8) gene mutation, genes in the major histocompatibility complex loci, and also polymorphisms in IL-10 and tumor necrosis factor-alpha are t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Blood Coagulation Factor Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to Introns

Share to Mutation

Share to Polymorphism, Genetic

Share to Turkey

Source

Identifiers

PMID: 18600086
DOI: 10.1097/MBC.0b013e3282f9b193

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18600086-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors.PMID 18600086Read ↗

F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors.Semantic proximity Read ↗

Molecular diagnosis of inversions resulting from intron 22 rearrangement of F8 gene in a patients with hemophilia A and their families and genotype-phenotype association analysisSemantic proximity Read ↗

Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel MutationsSemantic proximity Read ↗

Sequencing of the factor 8(F8) coding regions in 10 Turkish hemophilia A patients reveals three novel pathological mutations, and one rediagnosis of von Willebrand's disease type 2N.Semantic proximity Read ↗

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.Semantic proximity Read ↗

Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene.Semantic proximity Read ↗

Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy.Semantic proximity Read ↗

Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?Semantic proximity Read ↗

Genomic alterations in the F8 gene correlating with severe hemophilia A in Egyptian patients.Semantic proximity Read ↗

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.Semantic proximity Read ↗

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.Semantic proximity Read ↗

Molecular characterization of Hemophilia A in Mongolia: identification of a novel F8 frameshift mutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.